stem cell research

parkinsons-stem-cell-trial-what-happened-after-one-year

Parkinson’s Stem Cell Trial: What Happened After One Year?

Key Takeaways A one-year Parkinson’s stem cell trial called STEM-PD found no serious side effects linked to the cell product itself. Scientists used embryonic stem cells to grow dopamine producing cells, then transplanted them into eight patients with Parkinson’s disease. Six of seven surviving patients cut their Parkinson’s medication substantially,

Read More »
New Parkinson’s Cell Therapy Research-What Patients Should Know

New Parkinson’s Cell Therapy Research: What Patients Should Know

Quick Summary TreeFrog Therapeutics announced preclinical data for TFG‑001, a 3D neural microtissue therapy for Parkinson’s disease. The approach aims to replace damaged dopamine‑producing neurons. Preclinical models showed rapid dopamine release, nerve regrowth, and motor recovery. However, the work is still preclinical; a Clinical Trial Application is expected in 2027.

Read More »
Stem Cell Therapy-Could It Transform Medicine and Slow Ageing

Stem Cell Therapy: Could It Transform Medicine and Slow Ageing?

Quick Summary Stem cell therapy is making measured progress toward treating age-related diseases like vision loss, frailty, and Parkinson’s, but broad age reversal remains unproven. Recent clinical trials show improved mobility in frailty patients, while Parkinson’s and vision repair trials aim to replace specific damaged cells. However, safety risks persist,

Read More »
Alzheimer’s disease and stem cell therapy explained

Alzheimer’s disease and stem cell therapy explained

Quick Summary Stem cell therapy for Alzheimer’s uses mesenchymal stem cells (MSCs), neural stem cells (NSCs), or induced pluripotent stem cells (iPSCs) to repair damaged brain cells, reduce inflammation, and support the central nervous system. Early-stage patients may see improved memory and slower decline, but treatment is not yet a

Read More »